U.S. Post-Surgical Scar Treatment Market, by Product Type (Silicone sheets & Patches, Surgical tapes, Strips, Gels & Creams, and Others), by Channel (OTC, and Rx), by Scar Type (Atrophic Scars, Hypertrophic Scars, Keloid Scars, and Contracture Scars), by

U.S. Post-Surgical Scar Treatment Market, by Product Type (Silicone sheets & Patches, Surgical tapes, Strips, Gels & Creams, and Others), by Channel (OTC, and Rx), by Scar Type (Atrophic Scars, Hypertrophic Scars, Keloid Scars, and Contracture Scars), by Surgery Type (Caesarean Section, Joint Replacement, Appendectomy, Heart Surgery, Breast surgery, and Other), and by End User (Ambulatory Surgical Centers, Clinics, Home Care Settings, and Hospitals) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Any burn, injury, or trauma such as surgeries can cause a scar on the skin. Scarring is a natural healing process, which occurs after an injury. Its appearance and treatment depend on multiple factors such as the depth and size of the wound or the cut. It also depend upon the location of the wound, age, sex, and genes. There are various types of scars such as keloid scars, contracture scars, acne scars, and hypertrophic scars. Keloid scars are formed due to an over-aggressive healing process. They usually extend beyond their original location of the injury. Treatment of keloid scars include surgery, steroid injections, silicone sheets, and others. Hypertrophic scars are raised red scars and treatment of these scars include injection of steroids or silicone sheets.

Market Dynamics

Market players are engaged in inorganic growth activities such as acquisitions, and this is expected to drive growth of the U.S. post-surgical scar treatment market, over the forecast period. For instance, in April 2019, Merz, a company involved in aesthetics and neurotoxins, and Laboratoire HRA Pharma SAS, an innovative U.S. consumer healthcare company, entered into an agreement to acquire the asset purchase agreement, according to which HRA Pharma will acquire the U.S. rights to the Mederma brand of Merz, which includes products across the scar care, stretch marks, and skincare categories.
Moreover, in October 2019, 3M, a multinational conglomerate corporation operating in the fields of industry, worker safety, health care, and consumer goods, completed the acquisition of Acelity, Inc., a medical device company, to expand its surgical applications business, which include advanced wound care and specialty surgical applications marketed under the KCI brand (PROMOGRAN) in the developed economies such as the U.S.
Key features of the study:
This report provides an in-depth analysis of the U.S. post-surgical scar treatment market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the U.S. post-surgical scar treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Smith & Nephew Plc., 3M, Cardinal Health, Merz Pharma, Biodermis, Scar Heal, Inc., Mölnlycke Health Care AB, Implantech, Covalon Technologies Ltd., Bio Med Sciences, Polymer Science, Inc., and Neodyne Biosciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The U.S. post-surgical scar treatment market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the U.S. post-surgical scar treatment market
Detailed Segmentation:
U.S. Post-Surgical Scar Treatment Market, By Product Type:
Silicone sheets & Patches
Surgical tapes
Strips
Gels & Creams
Others
U.S. Post-Surgical Scar Treatment Market, By Channel:
OTC
Rx
U.S. Post-Surgical Scar Treatment Market, By Scar Type:
Atrophic Scars
Hypertrophic Scars
Keloid Scars
Contracture Scars
U.S. Post-Surgical Scar Treatment Market, By Surgery Type:
Caesarean Section
Joint Replacement
Appendectomy
Heart Surgery
Breast surgery
Others
U.S. Post-Surgical Scar Treatment Market, By End User:
Ambulatory Surgical Centers
Clinics
Home Care Settings
Hospitals
Company Profiles
Smith & Nephew Plc. *
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
3M
Cardinal Health
Merz Pharma
Biodermis
Scar Heal, Inc.
Mölnlycke Health Care AB
Implantech
Covalon Technologies Ltd.
Bio Med Sciences
Polymer Science, Inc.
Neodyne Biosciences, Inc.

“*” marked represents similar segmentation in other categories in the respective section.